Puretech Health Plc Stock Price Patterns
| PTCHF Stock | USD 1.85 0.12 6.94% |
Momentum 74
Buy Stretched
Oversold | Overbought |
Using PureTech Health hype-based prediction, you can estimate the value of PureTech Health plc from the perspective of PureTech Health response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in PureTech Health to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying PureTech because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
PureTech Health after-hype prediction price | USD 1.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
PureTech |
PureTech Health After-Hype Price Density Analysis
As far as predicting the price of PureTech Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PureTech Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of PureTech Health, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
PureTech Health Estimiated After-Hype Price Volatility
In the context of predicting PureTech Health's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PureTech Health's historical news coverage. PureTech Health's after-hype downside and upside margins for the prediction period are 0.18 and 3.52, respectively. We have considered PureTech Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PureTech Health is moderately volatile at this time. Analysis and calculation of next after-hype price of PureTech Health plc is based on 3 months time horizon.
PureTech Health Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as PureTech Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PureTech Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PureTech Health, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.17 | 1.68 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.85 | 1.85 | 0.00 |
|
PureTech Health Hype Timeline
PureTech Health plc is at this time traded for 1.85. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. PureTech is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.17%. %. The volatility of related hype on PureTech Health is about 0.0%, with the expected price after the next announcement by competition of 1.85. About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PureTech Health plc has Price/Earnings (P/E) ratio of 158.0. The entity recorded a loss per share of 0.21. The firm had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out PureTech Health Basic Forecasting Models to cross-verify your projections.PureTech Health Related Hype Analysis
Having access to credible news sources related to PureTech Health's direct competition is more important than ever and may enhance your ability to predict PureTech Health's future price movements. Getting to know how PureTech Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PureTech Health may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AVCTF | Avacta Group Plc | 0.00 | 0 per month | 0.00 | (0.13) | 1.03 | (5.13) | 35.79 | |
| HLOSF | Healios KK | 0.00 | 0 per month | 0.00 | (0.18) | 0.00 | (6.34) | 30.18 | |
| CLVLY | Clinuvel Pharmaceuticals Ltd | 0.00 | 0 per month | 1.42 | 0.02 | 3.55 | (2.76) | 11.55 | |
| BOVNF | BioInvent International AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NWBO | Northwest Biotherapeutics | 0.00 | 0 per month | 3.24 | 0.06 | 7.14 | (4.17) | 38.34 | |
| CLVLF | Clinuvel Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.14 | 1.75 | 0.00 | 14.74 | |
| MDCLF | MedinCell SA | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 392.69 | |
| RAONF | Race Oncology Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HUMDF | Hua Medicine | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FGHQF | Frontage Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PureTech Health Additional Predictive Modules
Most predictive techniques to examine PureTech price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PureTech using various technical indicators. When you analyze PureTech charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About PureTech Health Predictive Indicators
The successful prediction of PureTech Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PureTech Health plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PureTech Health based on analysis of PureTech Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PureTech Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PureTech Health's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for PureTech Pink Sheet analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |